Eric Karas
Tracked across 1 events · 6 articles · First seen Jun 26, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Eric Karas, Chief Commercial Officer of ARS Pharmaceuticals, also made projections about Neffy's commercial coverage that are being investigated for potential misleading statements.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Eric Karas live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard